Daratumumab and Belatacept for Desensitization
Clinical trial NCT04827979 · COMPLETED
Trial details
- NCT number
- NCT04827979
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2026-04-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.